Symptom-driven Maintenance and Reliever Treatment to Prevent Exacerbations in COPD

NCT02477397 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

201

Enrollment

OTHER

Sponsor class

Conditions

COPD

Interventions

DRUG: Spiromax Budesonide/formoterol
DRUG: Diskus Fluticasone/salmeterol

Sponsor

University Medical Center Groningen